188 related articles for article (PubMed ID: 35196595)
21. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities.
Tian XY; Zhang WX; Chen XY; Jia MQ; Zhang SY; Chen YF; Yuan S; Song J; Li J
Eur J Med Chem; 2024 Feb; 265():116079. PubMed ID: 38150962
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
Xu S; An B; Li Y; Luo X; Li X; Jia X
Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors.
Zhang S; Mo M; Lv M; Xia W; Liu K; Yu G; Yu J; Xu G; Zeng X; Cheng S; Xu B; Luo H; Meng X
Future Med Chem; 2023 Nov; 15(21):1967-1986. PubMed ID: 37937524
[No Abstract] [Full Text] [Related]
27. Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells.
Zhang H; Li M; Zhou X; Tang L; Chen G; Zhang Y
Eur J Med Chem; 2024 Jun; 272():116497. PubMed ID: 38759453
[TBL] [Abstract][Full Text] [Related]
28. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
[TBL] [Abstract][Full Text] [Related]
29. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL
Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization.
Wang G; Liu W; Peng Z; Huang Y; Gong Z; Li Y
Bioorg Chem; 2020 Oct; 103():104141. PubMed ID: 32750611
[TBL] [Abstract][Full Text] [Related]
31. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
Ren W; Deng Y; Ward JD; Vairin R; Bai R; Wanniarachchi HI; Hamal KB; Tankoano PE; Tamminga CS; Bueno LMA; Hamel E; Mason RP; Trawick ML; Pinney KG
Eur J Med Chem; 2024 Jan; 263():115794. PubMed ID: 37984295
[TBL] [Abstract][Full Text] [Related]
33. 1,4,5,6,7,8-Hexahydroquinolines and 5,6,7,8-tetrahydronaphthalenes: A new class of antitumor agents targeting the colchicine binding site of tubulin.
Shaheen MA; El-Emam AA; El-Gohary NS
Bioorg Chem; 2020 Jun; 99():103831. PubMed ID: 32388203
[TBL] [Abstract][Full Text] [Related]
34. Combretastatin A-4 sulfur-containing heterocyclic derivatives: Synthesis, antiproliferative activities and molecular docking studies.
Faouzi A; Arnaud A; Bancet A; Barette C; Preto J; Do CV; Jordheim LP; Bousfiha Z; Nguyen TTB; Verrière M; Farce A; Fauvarque MO; Barret R; Lomberget T
Eur J Med Chem; 2021 Apr; 215():113275. PubMed ID: 33618157
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
[TBL] [Abstract][Full Text] [Related]
36. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.
Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.
Wang C; Li Y; Liu T; Wang Z; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
Bioorg Chem; 2020 Nov; 104():103909. PubMed ID: 33142419
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of 1-(benzofuran-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
Qi ZY; Hao SY; Tian HZ; Bian HL; Hui L; Chen SW
Bioorg Chem; 2020 Jan; 94():103392. PubMed ID: 31669093
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
